All Monthly Communication Reports for Eli Lilly Canada Inc.

Lisa Matar, President and General Manager (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-85 of 85


  1. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-05-29
    Posted date: 2019-06-11
    Communication number: 6034-454844 View associated registration

  2. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bill Blair, Minister of Border Security and Organized Crime Reduction | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-05-24
    Posted date: 2019-06-14
    Communication number: 6034-455781 View associated registration

  3. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Kovacecvic, Assistant Deputy Minister | Finance Canada (FIN)
    • Suzy Mccdonald, Associate Assistant Deputy Minister | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-03-11
    Posted date: 2019-03-18
    Communication number: 6034-448302 View associated registration

  4. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry, Research and Development
    Communication date: 2019-03-07
    Posted date: 2019-03-18
    Communication number: 6034-448304 View associated registration

  5. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groeneweg, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology, Economic Development
    Communication date: 2019-01-16
    Posted date: 2019-01-28
    Communication number: 6034-444256 View associated registration

  6. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bill Blair, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2018-12-17
    Posted date: 2019-01-15
    Communication number: 6034-443750 View associated registration

  7. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Economic Development
    Communication date: 2018-12-04
    Posted date: 2019-01-13
    Communication number: 6034-443517 View associated registration

  8. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Guy Foregeron, Assistant Secretary, Regulatory Affairs Sector | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry, International Trade, Research and Development
    Communication date: 2018-11-14
    Posted date: 2018-11-19
    Communication number: 6034-439848 View associated registration

  9. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-10-25
    Posted date: 2018-11-01
    Communication number: 6034-436876 View associated registration

  10. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Daniel Albas, Opposition on Innovation, Science and Economic Developement Critic | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2018-10-23
    Posted date: 2018-11-09
    Communication number: 6034-437545 View associated registration

  11. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gianluca Cairo, Chief of Staff to Minister Bains | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2018-10-23
    Posted date: 2018-11-09
    Communication number: 6034-437542 View associated registration

  12. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John Knubley, Deputy Minister, ISED | Innovation, Science and Economic Development Canada (ISED)
    • Mark Schaan, Director General, Market Framework Policy branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2018-10-23
    Posted date: 2018-11-09
    Communication number: 6034-437537 View associated registration

  13. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2018-10-03
    Posted date: 2018-11-01
    Communication number: 6034-436875 View associated registration

  14. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-09-11
    Posted date: 2018-09-28
    Communication number: 6034-434203 View associated registration

  15. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-07-17
    Posted date: 2018-08-13
    Communication number: 6034-432191 View associated registration

  16. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-27
    Posted date: 2018-08-13
    Communication number: 6034-432193 View associated registration

  17. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor, Office of the Minister of Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development, Economic Development
    Communication date: 2018-06-11
    Posted date: 2018-06-14
    Communication number: 6034-428735 View associated registration

  18. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Maximilien Roy, Policy Advisor Office of the Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Health, Research and Development, Economic Development
    Communication date: 2018-06-11
    Posted date: 2018-06-14
    Communication number: 6034-428726 View associated registration

  19. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Policy Director | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-06-11
    Posted date: 2018-06-14
    Communication number: 6034-428679 View associated registration

  20. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Economic Development
    Communication date: 2018-05-17
    Posted date: 2018-08-13
    Communication number: 6034-428683 View associated registration

  21. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-04-10
    Posted date: 2018-04-12
    Communication number: 6034-423574 View associated registration

  22. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Abby Hoffman, Assistant Deputy Minister | Health Canada (HC)
    • Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • John Knubley, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Gianluca Cairo, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
    • David MacFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
    • Genevieve Hinse, Chief of Staff | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)
    • Hilary Travis, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2018-04-03
    Posted date: 2018-04-13
    Communication number: 6034-424116 View associated registration

  23. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2018-03-07
    Posted date: 2018-03-16
    Communication number: 6034-422586 View associated registration

  24. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • kathryn Nowers, Senior Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-12-07
    Posted date: 2017-12-07
    Communication number: 6034-414866 View associated registration

  25. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bill Blair, Parliamentry Secretary | House of Commons

    Subject Matter of the communication: Health, Industry, Research and Development
    Communication date: 2017-12-07
    Posted date: 2017-12-07
    Communication number: 6034-414864 View associated registration

  26. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)
    • Abby Hoffman, Assistant Deputy Minister | Health Canada (HC)
    • Kendal Weber, Associate Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Research and Development, Economic Development
    Communication date: 2017-11-14
    Posted date: 2017-12-13
    Communication number: 6034-415704 View associated registration

  27. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sarah Hussaini, Policy | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2017-11-01
    Posted date: 2017-11-03
    Communication number: 6034-411215 View associated registration

  28. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
    Communication date: 2017-11-01
    Posted date: 2017-11-03
    Communication number: 6034-411214 View associated registration

  29. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-10-10
    Posted date: 2017-10-23
    Communication number: 6034-410559 View associated registration

  30. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Frank Baylis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2017-09-19
    Posted date: 2017-09-22
    Communication number: 6034-408338 View associated registration

  31. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Corinne Guenette, Director, Life Science Industries, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Economic Development
    Communication date: 2017-09-18
    Posted date: 2017-09-22
    Communication number: 6034-408339 View associated registration

  32. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • douglas clark, Executive Director | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Economic Development
    Communication date: 2017-08-03
    Posted date: 2017-09-05
    Communication number: 6034-407323 View associated registration

  33. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bill Blair, Member of Parliament, Scarborough Southwest | House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, Research and Development
    Communication date: 2017-07-11
    Posted date: 2017-08-11
    Communication number: 6034-406575 View associated registration

  34. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kelly Gillis, Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development, Economic Development
    Communication date: 2017-06-20
    Posted date: 2017-07-18
    Communication number: 6034-405909 View associated registration

  35. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Research and Development, Economic Development
    Communication date: 2017-05-23
    Posted date: 2017-05-23
    Communication number: 6034-401385 View associated registration

  36. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2017-01-30
    Posted date: 2017-02-08
    Communication number: 6034-393380 View associated registration

  37. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2016-11-17
    Posted date: 2016-11-29
    Communication number: 6034-389106 View associated registration

  38. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Economic Development
    Communication date: 2016-10-11
    Posted date: 2016-11-14
    Communication number: 6034-387639 View associated registration

  39. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ian Foucher, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2016-06-10
    Posted date: 2016-07-15
    Communication number: 6034-381305 View associated registration

  40. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Justin To, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2016-06-10
    Posted date: 2016-07-15
    Communication number: 6034-381302 View associated registration

  41. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dev Saxena, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2016-06-10
    Posted date: 2016-07-15
    Communication number: 6034-381295 View associated registration

  42. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John Oliver, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Research and Development, Economic Development
    Communication date: 2016-05-10
    Posted date: 2016-05-24
    Communication number: 6034-377669 View associated registration

  43. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Celina Caesar-Chavannes, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2016-05-10
    Posted date: 2016-05-24
    Communication number: 6034-377668 View associated registration

  44. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2016-05-09
    Posted date: 2016-06-15
    Communication number: 6034-377670 View associated registration

  45. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rachael Harder, Member of Parliament | House of Commons
    • Colin Carrie, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2016-05-03
    Posted date: 2016-05-03
    Communication number: 6034-375606 View associated registration

  46. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brian Clow, Chief of Staff | Global Affairs Canada (GAC)
    • Sarah Husseini, Policy Advisor | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, Intellectual Property, International Trade, Economic Development
    Communication date: 2016-04-13
    Posted date: 2016-04-15
    Communication number: 6034-374735 View associated registration

  47. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Corinne Guenette, Director, Life Science Industries, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, International Trade, Research and Development, Economic Development
    Communication date: 2016-04-13
    Posted date: 2016-04-15
    Communication number: 6034-374733 View associated registration

  48. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Len Webber, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2016-04-12
    Posted date: 2016-05-03
    Communication number: 6034-374204 View associated registration

  49. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marco Mendicino, MP | House of Commons

    Subject Matter of the communication: Intellectual Property, International Trade, Research and Development
    Communication date: 2016-04-07
    Posted date: 2016-04-15
    Communication number: 6034-374730 View associated registration

  50. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marc Serre, MP | House of Commons

    Subject Matter of the communication: Intellectual Property, International Trade, Economic Development
    Communication date: 2016-03-22
    Posted date: 2016-04-15
    Communication number: 6034-374725 View associated registration

  51. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Terry Beech, Parliamentary Secretary | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Intellectual Property, International Trade, Taxation and Finance, Research and Development
    Communication date: 2016-03-21
    Posted date: 2016-04-15
    Communication number: 6034-374722 View associated registration

  52. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francois-Philippe Champagne, Parliamentary Secretary | Finance Canada (FIN)

    Subject Matter of the communication: Industry, Intellectual Property, Research and Development, Economic Development
    Communication date: 2016-03-07
    Posted date: 2016-03-11
    Communication number: 6034-371452 View associated registration

  53. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Thomas Mulcair, Leader New Democratic Party | House of Commons

    Subject Matter of the communication: Intellectual Property, International Trade, Economic Development
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371448 View associated registration

  54. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rona Ambrose, Leader of the Opposition | House of Commons

    Subject Matter of the communication: Industry, International Trade, Economic Development
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371443 View associated registration

  55. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Earl Dreeshan, Vice-Chair | House of Commons

    Subject Matter of the communication: Industry, Science and Technology, Research and Development, Economic Development
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371440 View associated registration

  56. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tracey Ramsey, Critic | House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371438 View associated registration

  57. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Karen Vecchio, Critic | House of Commons

    Subject Matter of the communication: Industry, International Trade, Economic Development
    Communication date: 2016-02-23
    Posted date: 2016-03-15
    Communication number: 6034-371435 View associated registration

  58. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Terry Beech, Parliamentary Secretary | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Research and Development, Economic Development
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371431 View associated registration

  59. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Claude Poissant, Parliamentary Secretary | Agriculture and Agri-Food Canada (AAFC)

    Subject Matter of the communication: Industry, International Trade, Research and Development
    Communication date: 2016-02-23
    Posted date: 2016-03-11
    Communication number: 6034-371429 View associated registration

  60. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sarah Hussaini, Policy Advisor | Global Affairs Canada (GAC)
    • Simon Beauchemin, Special Assistant, Parliamentary Affairs | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry, Intellectual Property, Research and Development
    Communication date: 2016-01-07
    Posted date: 2016-02-15
    Communication number: 6034-366601 View associated registration

  61. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Deborah Levy, Chief of Staff | House of Commons

    Subject Matter of the communication: Industry, Science and Technology
    Communication date: 2014-09-29
    Posted date: 2014-10-15
    Communication number: 6034-335847 View associated registration

  62. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Cynthia Tran, Advisor, Stakeholder Relations and Outreach | Prime Minister's Office (PMO)
    • Virginie Bonneau, Regional Affairs Advisor, Quebec | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2014-09-29
    Posted date: 2014-10-15
    Communication number: 6034-335843 View associated registration

  63. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Maxime Laliberte, Policy Advisor | House of Commons

    Subject Matter of the communication: Industry, Science and Technology, Taxation and Finance
    Communication date: 2014-09-25
    Posted date: 2014-10-15
    Communication number: 6034-335835 View associated registration

  64. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Virginie Bonneau, Regional Affairs Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Industry
    Communication date: 2014-07-23
    Posted date: 2014-08-26
    Communication number: 6034-332329 View associated registration

  65. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dan Brown, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2014-02-24
    Posted date: 2014-03-15
    Communication number: 6034-319372 View associated registration

  66. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dan Harris, Memeber of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-02-18
    Posted date: 2014-03-16
    Communication number: 6034-319532 View associated registration

  67. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eve Adams, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-01-09
    Posted date: 2014-02-15
    Communication number: 6034-316129 View associated registration

  68. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Devinder Shory, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2013-12-04
    Posted date: 2014-02-15
    Communication number: 6034-316130 View associated registration

  69. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Wilks, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2013-11-28
    Posted date: 2013-12-15
    Communication number: 6034-307911 View associated registration

  70. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dany Morin, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2013-11-27
    Posted date: 2013-12-03
    Communication number: 6034-307910 View associated registration

  71. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Art Eggleton, Senator | Senate of Canada

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2013-11-26
    Posted date: 2013-12-15
    Communication number: 6034-307912 View associated registration

  72. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Chris Charlton, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2013-11-25
    Posted date: 2013-12-03
    Communication number: 6034-307909 (amended from 6034-307891) View associated registration

  73. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ron Cannan, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2013-11-18
    Posted date: 2013-12-03
    Communication number: 6034-307889 View associated registration

  74. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dan Harris, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2013-10-10
    Posted date: 2013-12-03
    Communication number: 6034-307929 View associated registration

  75. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gary Goodyear, Minister of State | Federal Economic Development Agency for Southern Ontario (FedDev)
    • Mark Schaan, Director, Pharmaceutical Policy | Industry Canada
    • Thomas Coughlan, Policy Advisor | Federal Economic Development Agency for Southern Ontario (FedDev)

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology
    Communication date: 2013-04-23
    Posted date: 2013-05-31
    Communication number: 6034-275330 View associated registration

  76. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gary Doer, Canada's Ambassador to the US | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Health, Intellectual Property, International Trade
    Communication date: 2013-03-05
    Posted date: 2013-05-31
    Communication number: 6034-275329 View associated registration

  77. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dan Harris, Member of Parliament | House of Commons

    Subject Matter of the communication: Intellectual Property, Science and Technology
    Communication date: 2013-01-25
    Posted date: 2013-04-16
    Communication number: 6034-269836 View associated registration

  78. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisory | Industry Canada

    Subject Matter of the communication: Intellectual Property
    Communication date: 2012-10-29
    Posted date: 2012-11-15
    Communication number: 6034-245083 View associated registration

  79. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rick Stewart, Secretary to the Cabinet | Privy Council Office (PCO)
    • Sylvain Laporte, CEO, Commissioner of Patents | Industry Canada
    • Chris Evans, Chair, Patents Appeals Board | Industry Canada

    Subject Matter of the communication: Intellectual Property
    Communication date: 2012-10-16
    Posted date: 2012-11-15
    Communication number: 6034-245019 View associated registration

  80. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andre Bachand, Senior Advisor | Prime Minister's Office (PMO)
    • Sean Speer, Senior Economic Policy Advisor | Prime Minister's Office (PMO)
    • Andrea van Vugt, Policy Advisor | Prime Minister's Office (PMO)
    • Phil Harwood, Policy Advisor | Prime Minister's Office (PMO)
    • Stefan Stefanov, Intern | Prime Minister's Office (PMO)
    • Sean O'Leary, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2012-02-28
    Posted date: 2012-04-26
    Communication number: 6034-220327 View associated registration

  81. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Karen Dodds, ADM | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2010-05-31
    Posted date: 2010-08-03
    Communication number: 6034-152959 View associated registration

  82. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ron Parker, Senior ADM | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2010-05-31
    Posted date: 2010-08-03
    Communication number: 6034-152958 View associated registration

  83. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tony Clement, Minister of Industry | Industry Canada

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2010-05-04
    Posted date: 2010-08-03
    Communication number: 6034-152957 View associated registration

  84. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Richard Discerni, Deputy Minister, Industry Canada | Industry Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology, Taxation and Finance
    Communication date: 2009-05-28
    Posted date: 2009-07-06
    Communication number: 6034-111876 View associated registration

  85. Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tony Clement, Industry Minister | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance
    Communication date: 2009-05-18
    Posted date: 2009-07-06
    Communication number: 6034-111874 View associated registration



Return to Eli Lilly Canada Inc.